title: [Observation on therapeutic effect of comprehensive therapy on optic atrophy complicated by cerebral palsy].
abstract: OBJECTIVE
  To assess therapeutic effect of combined treatment of Chinese medicine and western medicine on optic atrophy complicated by cerebral palsy.
  
  
  METHODS
  One hundred and seventeen cases were divided into an observation group (n = 79) and a control group (n = 38). The control group were treated with routine western medicine treatment including neurotrophic drugs and high pressure oxygen, etc. and the observation group with acupuncture at Ganshu (BL 18), Pishu (BL 20), Chengqi (ST 1), etc. and injection of 0.2-0.3 mL Compound Danshen Injectio into Qiuhou (EX-HN 7), on the basis of the same treatment of western medicine as that in the control group. Fundus examination and the tracing body angle detection were conducted before and after treatment and the therapeutic effects were assessed in the two groups.
  
  
  RESULTS
  The total effective rate was 91.1% in the observation group and 60.5% in the control group with a significant difference between the two groups (P < 0.001); after treatment the angle of tracing body significantly increased in the two groups (P < 0.01) with the observation group better than the control group (P < 0.01).
  
  
  CONCLUSIONS
  The combined treatment of Chinese medicine and western medicine is an effective therapy for optic atrophy complicated by cerebral palsy.
authors.affiliation: Rehabilitation Center, Hunan Children's Hospital, Changsha 410007, China. wpaoqiu@yahoo.cn
authors.forename: Pao-Qiu
authors.initials: PQ
authors.lastname: Wang
authors.forename: Zhi-Xiong
authors.initials: ZX
authors.lastname: Liu
authors.forename: Hong-Wen
authors.initials: HW
authors.lastname: Liu
authors.forename: Wei-Hong
authors.initials: WH
authors.lastname: Yang
authors.forename: Mao-Wei
authors.initials: MW
authors.lastname: Xiong
mesh_terms: D015670:Acupuncture Therapy; D002547:Cerebral Palsy / Q000150:complications*; D003131:Combined Modality Therapy; D004358:Drug Therapy; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009896:Optic Atrophy / Q000628:therapy*